Is flank pain associated with post‑infusion of intravenous immunoglobulin (IVIG)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Flank Pain and IVIG: Association and Clinical Significance

Yes, flank pain can be associated with post-infusion IVIG, primarily as a manifestation of acute renal complications, though it is not among the most commonly reported adverse effects.

Understanding IVIG-Associated Adverse Effects

IVIG adverse effects are well-documented and classified into immediate and delayed reactions. The most recent comprehensive guideline 1 from 2025 describes that immediate mild effects occur in approximately 80% of patients and include flu-like symptoms (fever, chills, fatigue), while moderate effects (dermatological reactions) occur in about 6% of patients 1.

Renal Complications and Flank Pain

Flank pain specifically relates to IVIG-associated nephrotoxicity, which is a recognized delayed adverse effect. The FDA drug label 2 explicitly documents acute renal failure as a serious adverse reaction following IVIG administration, characterized by:

  • Elevation of serum creatinine
  • Acute tubular necrosis
  • Potentially reversible or irreversible kidney damage

The mechanism involves osmotic injury, particularly with sucrose-containing IVIG products 3. When renal impairment occurs, patients may experience flank pain as a symptom of acute kidney injury.

Clinical Context and Risk Factors

Delayed adverse events, including renal impairment, affect less than 1% of patients but are usually severe 1. The renal complications can manifest as:

  • Transient ischemia
  • Acute tubular obstruction 1
  • Oliguria with increased serum creatinine 4

Research evidence 3 demonstrates that acute renal failure occurs predominantly with sucrose-containing formulations, and all four patients described in one case series experienced return to baseline renal function after IVIG discontinuation.

High-Risk Patient Populations

Patients at increased risk for renal complications (and potentially flank pain) include those with 5, 3:

  • Pre-existing renal disease
  • Dehydration
  • Diabetes mellitus
  • Advanced age
  • Hypertension
  • Concurrent nephrotoxic medications
  • Hyperviscosity

Prevention and Management Strategies

To minimize risk of renal complications:

  • Ensure adequate hydration before IVIG administration 2
  • Monitor serum creatinine levels 4
  • Use non-sucrose-containing IVIG products in high-risk patients 5, 3
  • Administer at low concentration and slow infusion rate 5
  • Supervise urine output during and after infusion 5

Common Pitfalls

While flank pain can occur with IVIG-related renal injury, it is important not to confuse this with the more common immediate adverse effects such as back pain, which occurs as part of the general infusion reaction syndrome and is not specifically renal in origin 5. The distinction is critical:

  • Immediate back/flank discomfort: Part of general infusion reaction, occurs during or immediately after infusion, typically mild and transient
  • Delayed flank pain with renal impairment: Associated with oliguria, rising creatinine, and occurs hours to days post-infusion, requires immediate evaluation

If flank pain develops post-IVIG infusion, immediately assess renal function (creatinine, BUN, urine output) to distinguish between benign musculoskeletal discomfort and serious renal complications requiring intervention.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.